Gene Therapy, Heart Failure

Gene Therapy Reverses Heart Failure in Pig Trials
TUESDAY, Dec. 10, 2024 (HealthDay News) -- Failing hearts nearly returned to full function in laboratory pigs after they received an experimental gene therapy. New research shows the gene therapy didn’t just prevent heart failure from worsening in four lab pigs, but actually prompted hearts to repair and grow stronger.
Heart failure is reversed with new gene therapy in animal study: ‘Unprecedented recovery’
Heart failure has historically been irreversible, but a new study suggests that could change. At the University of Utah, scientists used a new gene therapy that reversed heart failure in animals.
New gene therapy reverses heart failure effects in animals, human trials pending
A new study using gene therapy from the University of Utah reversed the impact of heart failure in pigs. Can it work on humans?
New Gene Therapy Reverses Heart Failure in Large Animal Model
The therapy increases the amount of blood the heart can pump and dramatically improves survival, in what a paper describing the results calls “an unprecedented recovery of cardiac function.”
Promising gene therapy could transform heart failure treatment
A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model.
New gene therapy found to reverse heart failure effects in large animals
Researchers found a genetic therapy that could be used to reverse heart failure. A recent study found that it worked on large animals.
Gene therapy reverses heart failure in new trials
In a new study, failing hearts nearly returned to full function in laboratory pigs after they received an experimental gene therapy.
Cure for heart failure on horizon after scientists cure pigs with gene therapy
A cure for heart failure could be on the horizon after scientists inserted a gene into ailing pigs, allowing their hearts to pump blood at normal levels again. Researchers at the University of Utah want to begin human trials next year,
BioPharma Dive1d
UniQure shares soar on chance of speedy approval for Huntington’s therapy
The company now says that, during a recent meeting with the FDA, the two parties agreed on some key elements for an ...
pharmaphorum19h
uniQure rockets on map to market for Huntington's therapy
Crucially for the Netherlands-based biopharma company, the FDA has said that the composite Unified Huntington's Disease ...
Gene therapy developer's stock doubles after FDA grants accelerated approval
The FDA will allow uniQure NV to seek accelerated approval for its Huntington’s disease gene therapy more than doubled the ...
Gene therapy uptake in sickle cell stays slow, despite patient interest
A lengthy treatment process, coupled with weighty risks for recipients to consider, has resulted in plodding adoption of ...
Researchers unlock new gene therapy targets for diabetic kidney disease
New potential therapeutic targets have been identified for diabetic kidney disease (DKD)—the leading cause of kidney failure ...
Breakthrough gene therapy offers new hope to child with muscular dystrophy
Monroe Carell was a natural fit to offer the new therapy. Its multidisciplinary DMD Clinic, co-directed by Burnette, Soslow ...
Science Daily15h
Gene therapy fixes major cause of stillbirth, premature birth in guinea pig model
The placenta, or afterbirth, is considered sacred by some cultures, its pivotal role in pregnancy recognized as far back as the raising of Egypt's pyramids. It provides nutrients and oxygen to the ...
FiercePharma14h
Vertex, Saudi Arabia ink memorandum of understanding to boost local gene therapy manufacturing
Two Saudi Arabian agencies signed on with Vertex Pharmaceuticals to help boost the countr | The Vertex agreement is part of ...